biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Jds website

<< Previous

Bullboard Posts

Next >>

Comment by narmacon Feb 16, 2021 7:59am

147 Views

Post# 32571324

RE:RE:Jds website

Huuummm,,,,,,it would be nice to see this .48 cent close on Friday turn into an .84 cent open this morning or one close at hand!!!!,,,,,,I am tingling all over for DrDR to bring it on these next couple of weeks!!!!!!!,,,,,wooohoooo,,,,yeppper,,,,,BTI,,,,,,to dahhhhhhh moooooooooooooon!!!!,,and onto interstellar space after this first leg up!!!!

NB*** Over all these years John Davenport has continued to be an important asset to all investors, be it they own shares or are still on the sidelines. Make no mistake about it!! The majority of readers here uinderstand this very point.

<< Previous

Bullboard Posts

Next >>

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal